Cognitive, neuropsychological and emotional-behavioural functioning in a sample of children with myotonic dystrophy

Federica S Ricci1, Martina Vacchetti1, Chiara Brusa1

  • 1Department of Public Health and Pediatric Sciences, Section of Child and Adolescent Neuropsychiatry, University of Turin, Italy.

Insights

This study assessed cognitive and behavioral functions in children with myotonic dystrophy type 1 (DM1), finding intellectual decline over two years. Further research is needed to understand DM1

Area of Science:

  • Pediatric Neurology
  • Neurodevelopmental Disorders
  • Myotonic Dystrophy Type 1 Research

Background:

  • Myotonic dystrophy type 1 (DM1) is a multisystem disorder with significant impact on neurological development.
  • Understanding the trajectory of cognitive and behavioral functioning in affected children is crucial for early intervention.

Purpose of the Study:

  • To assess the feasibility of evaluating cognitive, neuropsychological, and emotional-behavioral functions in children with DM1.
  • To prospectively estimate changes in these functions over time in a pediatric DM1 cohort.

Main Methods:

  • An observational longitudinal study involving 10 children (aged 1.5-16 years) with DM1, including congenital and childhood forms.
  • Standardized assessments of intellectual, neuropsychological, and emotional-behavioral functioning were administered at baseline and repeated after two years for six patients.

Main Results:

  • Intellectual disability was prevalent at baseline in both congenital and childhood DM1 groups.
  • A significant reduction in developmental/intelligence quotient was observed after two years in re-tested patients.
  • Baseline evaluations revealed impairments in visuospatial skills and attention, with no clear two-year trend; emotional-behavioral scores were heterogeneous without discernible trends.

Conclusions:

  • Longitudinal assessment of central nervous system (CNS) functions in children with DM1 is essential.
  • A comprehensive evaluation protocol should encompass cognitive, neuropsychological, emotional, and behavioral domains.
  • Larger longitudinal studies are required to accurately map functional trajectories and guide clinical practice for pediatric DM1.
Abstract

Related Concept Videos

Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.2K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.1K